Anne Dagallier

Anne Dagallier has extensive work experience in various roles in the pharmaceutical and research field. Anne is currently serving as the Chief Business Officer at Enterome since March 2021. Prior to their current position, they worked at Sanofi for nearly two decades, holding multiple roles such as Head of CHC Alliances & In-Licenses / Global Alliance Management / Strategy & Business Development, Director Corporate license China & Emerging Market / Strategy & Business Development, Head of External Innovation Infectious Diseases, Director Corporate License / Strategy & Business Development, and Manager Corporate License / Strategy & Business Development. Anne started their career as a Senior Researcher in Drug Design at Sanofi in 2002. Before joining Sanofi, Anne worked as an Academic Researcher at CNRS and as a Postdoctoral Fellow in Molecular Modeling at Mount Sinai School of Medicine, New York.

Anne Dagallier completed their Doctor of Philosophy (Ph.D.) in Molecular Biophysics from Pierre and Marie Curie University from 1994 to 1997. Anne further pursued their education at ESSEC Business School, where they obtained an EMBA (Executive Master of Business Administration) from 2008 to 2009.